Rockville biotech receives patent for tech that can identify patients at-risk of opioid addiction

HSR.health CEO Ajay Gupta

Rockville-based HSR.health announced this morning that the United States Patent and Trademark Office (USPTO) has issued a patent for the firm's novel use of geospatial tech, advanced AI models, and sets of social determinants of health data to identify patients at risk of opioid addiction. The technology also can identify patients at risk of having an overdose in the next 12 months. Overall, the purpose is to mitigate these negative outcomes before they happen, the company said.

HSR.health CEO Ajay Gupta said this morning that the issuing of the patent "is an acknowledgement of the uniqueness of our health-focused spatial data infrastructure." The now-patented tech can also be applied to pre-diabetic patients. Other areas of focus for the firm are reducing hospital readmissions, and assisting countries with pandemic response efforts.

Six additional HSR.health patent applications are now before the USPTO, related to geospatial tech, data and AI models. Montgomery County's biotech sector continues to be the bright spot amid an otherwise-moribund county economy.